46
Participants
Start Date
August 31, 2016
Primary Completion Date
November 30, 2019
Study Completion Date
April 20, 2020
Allo-MSCs
20 transendocardial injections of 0.4ml allo-MSCs administered to the left ventricle via NOGA Myostar injection catheter (single procedure)
Placebo
20 transendocardial injections of 0.4ml Buminate solution administered to the left ventricle via NOGA Myostar injection catheter (single procedure)
University of Florida-Department of Medicine, Gainesville
University of Miami-Interdiciplinary Stem Cell Institute, Miami
University of Louisville, Louisville
Indiana Center for Vascular Biology and Medicine, Indianapolis
Minneapolis Heart Institute Foundation, Minneapolis
Texas Heart Institute, Houston
Stanford University School of Medicine, Stanford
National Heart, Lung, and Blood Institute (NHLBI)
NIH
The University of Texas Health Science Center, Houston
OTHER